A detailed history of Royal Capital Wealth Management, LLC transactions in Organon & Co. stock. As of the latest transaction made, Royal Capital Wealth Management, LLC holds 14,407 shares of OGN stock, worth $276,326. This represents 0.23% of its overall portfolio holdings.

Number of Shares
14,407
Previous 14,373 0.24%
Holding current value
$276,326
Previous $270,000 10.37%
% of portfolio
0.23%
Previous 0.22%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$17.45 - $21.96 $593 - $746
34 Added 0.24%
14,407 $298,000
Q1 2024

May 15, 2024

BUY
$13.78 - $18.8 $41,863 - $57,114
3,038 Added 26.8%
14,373 $270,000
Q4 2023

Feb 07, 2024

BUY
$10.95 - $17.32 $124,118 - $196,322
11,335 New
11,335 $163,000
Q4 2022

Feb 14, 2023

BUY
$23.31 - $28.61 $185,897 - $228,164
7,975 New
7,975 $223,000
Q2 2022

Aug 16, 2022

BUY
$31.66 - $38.9 $231,719 - $284,709
7,319 New
7,319 $247,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $4.88B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Royal Capital Wealth Management, LLC Portfolio

Follow Royal Capital Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Capital Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Royal Capital Wealth Management, LLC with notifications on news.